PTX

8.00%

4.6¢ prescient therapeutics limited

Sorry for the misunderstanding. I didn't infer that you (as a...

First 397 Last

Share
Profile

Follow
Shellbell

7,956 Posts.

3409

23/02/24

09:53

Post #: 72553193
Share

Originally posted by threebeez: ↑

You may well be right about Bec for you surely follow it more closely than myself.

My point is that there is plenty to do for a small group and if there was some news that could be shared to help boost the SP I am sure we would hear about it ASAP. If your assumption about CellPryme is spot on and I do not doubt you are right - then I would have no objection to having it released upon completion. I do not understand why you would think that I would object?

Yes the share price has taken a battering and many feel the loss especially if they need the money now. But that is the nature of all speculative investments - they rise and fall on a whim and there is nothing management can do other than meet commitments. There is no balance sheet adjustments, no staff to sack, and no alternative research to turn too to boost shareholder sentiment.

It is obvious to me that SYC in particular is being blamed for the loss of SP, hence individuals loss of book value. To me the logic is that he alone can only be blamed if 1. He made the individuals decision to invest or 2. That he has done something illegal and I am sure he did neither.
I cannot understand the fact that many people expect an almost continuous SP increase and definitely no SP retracement from a small speculative biotech. Such expectations defy the logic of the buyer/seller marketplace. A few disgruntled traders can start a rout or in this case a prolonged downturn because he didn't tell them what he will be doing next week or did last week when it is none of their business.
I blame SYC for being far too friendly and allowing phone and email conversations with all and as-sundry for it leads to the current situation where he would be on the phone or email all day every day or making small changes to the almost monthly webcasts rather than doing his job. What could be said? "I cannot find a new cancer treatment this week to boost the SP, I can only complete the work in progress and hope to find another way of boosting the SP next week" or more correctly "I can walk through water and pass water but am unable to walk on water"

I do not know SYC as in we have never met but he seems to me to be as expected and my BS detector does not get triggered in any communication - which is rare for me. I have made a lot of money and lost a lot of money from various investments and in most complex organizations the boss takes the blame for the bad SP gyrations and is revered for the good ones.
With speculative biotech's it is different where almost all investments fail to reach approval. Anyone investing in biotech's that does not understand that is out of their depth. I expect PTX 100, CellPryme and OmniCAR to ultimately reach approval for they appear to be far better than what is available. I will however exit in an instance if something new appears that changes that expectation.

I find the current whining, blame shifting and expectation of near term magical solutions to the SP from SYC a lot of rot and commend those that have the smarts or wherewithal to take advantage of those that exit prematurely to crystalize a loss. That is the nature of investing in speculative stocks - if you don't know which end is up then you are surely in trouble.

Expand

Sorry for the misunderstanding. I didn't infer that you (as a long-term investor) would object to any release but was confirming your thoughts that you, like the market, should perhaps not be expecting anns at every turn. I agree with your sentiments.

PTX Price at posting: 4.8¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

RAG

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

CXU

Cauldron Energy reports "excellent" uranium assays in latest drill run

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

SHN

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

NWH

NRW Holdings inks $109M deal with BHP for works at Jimblebar

A3D

Defence MOU for propulsion systems pushes Aurora Lab shares higher

TIG

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

IMA

Issues emerging as Australian companies tackle critical minerals challenge

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

There are more pages in this discussion • 137 more messages in this thread...

First 397 Last

Add PTX (ASX) to my watchlist

(20min delay)
Last 4.6¢		Change -0.004(8.00%)		Mkt cap ! $37.04M

Open	High	Low	Value	Volume
4.9¢	4.9¢	4.5¢	$27.48K	578.7K

Buyers (Bids)

No.	Vol.	Price($)
1	49107	4.6¢

Sellers (Offers)

Price($)	Vol.	No.
4.7¢	100000	1

View Market Depth

No.	Vol.	Price($)
1	49107	0.046
2	49424	0.045
2	40000	0.044
4	301904	0.042
7	399000	0.041

Price($)	Vol.	No.
0.047	100000	1
0.048	2664	1
0.050	177119	2
0.051	277227	2
0.052	10500	1

Last trade - 16.10pm 11/10/2024 (20 minute delay)

PTX (ASX) Chart

Sorry for the misunderstanding. I didn't infer that you (as a...

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Cauldron Energy reports "excellent" uranium assays in latest drill run

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Defence MOU for propulsion systems pushes Aurora Lab shares higher

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

Issues emerging as Australian companies tackle critical minerals challenge

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Sorry for the misunderstanding. I didn't infer that you (as a...

Top Stories

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Cauldron Energy reports "excellent" uranium assays in latest drill run

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Defence MOU for propulsion systems pushes Aurora Lab shares higher

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

Issues emerging as Australian companies tackle critical minerals challenge

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News